Author: John C. Goodman

Much of the slowdown in drug development has been caused by the accumulated weight of decades of regulatory requirements, piled one atop another over years. The paperwork burden alone can be enormous: Novo Nordisk’s former chief scientific officer once noted that the documentation required to request approval for two insulin products, if printed and stacked, would rise higher than the Empire State Building….

Source: “Doctors Who Discover Miracle Drugs Worry About Medicine’s Future,” New York Times.